JSPR · Jasper Therapeutics, Inc.
$0.70
+0.00 (+0.07%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$23.28M
Shares
33.27M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-26 | 2026-08-21 | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-14 | — | |
| 8-K | 2026-08-03 | 2026-07-31 | |
| 8-K | 2026-07-31 | — | |
| 8-K | 2026-07-17 | 2026-07-16 | |
| 8-K | 2026-07-16 | — | |
| DEF 14A | 2026-06-15 | 2026-07-31 | |
| 8-K | 2026-06-09 | 2026-06-03 | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-21 | 2026-05-15 | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2026-01-07 | 2026-01-02 | |
| 8-K | 2025-12-02 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-09-19 | 2025-09-18 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-07-09 | 2025-07-08 | |
| 8-K | 2025-07-07 | — | |
| 8-K | 2025-07-03 | — | |
| 8-K | 2025-06-16 | 2025-06-14 | |
| DEF 14A | 2025-05-19 | 2025-07-03 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-03-19 | 2025-03-14 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-08 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-15 | 2024-10-14 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-20 | 2024-06-17 | |
| 8-K | 2024-06-12 | 2024-06-06 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-22 | 2024-06-06 | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-02-06 | — | |
| 8-K | 2024-01-04 | 2024-01-03 | |
| 8-K | 2024-01-02 | — | |
| 8-K | 2023-12-20 | 2023-12-15 | |
| DEF 14A | 2023-11-20 | 2023-12-15 |
Showing 1–50 of 122 filings
Key facts
CIK
1788028
CUSIP
471871202
13F (30d)
52 filings
51 filers
Visit website
Investor relations